BOK Financial’s Replimune Group REPL Stock Holding History

BOK Financial’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-15	Closed	-$126	–	1309
2023 Q4	$126	Buy	+15	New	+$174	﹤0.01%	1256

Other funds holding REPL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BOK Financial's REPL Position: Q1 2024 in Review

BOK Financial sold out of Replimune Group (REPL) in Q1 2024, closing a stake of 15 shares — an estimated $126 sold.

BOK Financial first reported a position in REPL in Q4 2023 and held it in 1 quarter. The position peaked at $126 in Q4 2023. 150 funds tracked by Wall St. Rank hold REPL as of Q1 2024.

BOK Financial reported no remaining Replimune Group position as of Q1 2024 after selling out during the quarter.
BOK Financial sold 15 Replimune Group shares in Q1 2024, an estimated $126.
BOK Financial first reported a position in Replimune Group in Q4 2023 and held it in 1 quarter.
BOK Financial's Replimune Group position peaked at $126 in Q4 2023.
150 funds tracked by Wall St. Rank held Replimune Group as of Q1 2024.

Based on BOK Financial's 13F filing for Q1 2024, filed 15 May 2024.